MENU
IMMX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Immix Biopharma (IMMX) Ownership - Who owns Immix Biopharma?
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications... Show more
Profile
Industry
N/A
Address
11400 West Olympic Boulevard
Phone
+1 310 651-8041
Employees
17
Web
https://www.immixbio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
66.63M
P/E Ratio
N/A
Total Cash
15.92M
Projected Growth
N/A
Total Debt
1.06M
Revenue
N/A
Risk (Beta)
0.19
Dividend Yield
N/A
Total Cash/Share
0.57
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
IMMX
Capitalization
66.6M
P/E Ratio
N/A
Risk (Beta)
0.19
Dividend Yield
N/A
Total Cash
15.9M
Total Cash/Share
0.57
Total Debt
1.06M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
9.59M
P/B Ratio
6.94
Cash Flow
N/A
Earnings
-0.69
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2.79K
Current Ratio
1.80
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-21.62M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-77.05
Shares Held By Institutions
6.42M
Shares Outstanding - Current
27.9M
Total Liabilities
10.3M
Total Volume MTD
N/A
Value
N/A
Gain YTD
8.636
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. IMMX showed earnings on May 28, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
11400 West Olympic Boulevard
Phone
+1 310 651-8041
Employees
17
Web
https://www.immixbio.com